Vitrolife Group completes refinancing facility backed by leading Nordic Banks
Vitrolife (OTC:VTRLY) has successfully secured a EUR 300 million loan agreement comprising a term loan and revolving credit facility. The financing arrangement, backed by leading Nordic banks including Nordea, SEB, and new lender AB Svensk Exportkredit, features a three-year tenor with two one-year extension options.
The term loan will be utilized to refinance existing debt, while the revolving credit facility will be available for general corporate purposes. The addition of AB Svensk Exportkredit as a new lender highlights Vitrolife Group's strong credit profile and export focus.
Vitrolife (OTC:VTRLY) ha ottenuto con successo un accordo di prestito da 300 milioni di euro che include un prestito a termine e una linea di credito revolving. L'accordo finanziario, supportato da importanti banche nordiche come Nordea, SEB e il nuovo finanziatore AB Svensk Exportkredit, prevede una durata di tre anni con due opzioni di proroga di un anno ciascuna.
Il prestito a termine sarà utilizzato per rifinanziare il debito esistente, mentre la linea di credito revolving sarà destinata a scopi aziendali generali. L'ingresso di AB Svensk Exportkredit come nuovo finanziatore sottolinea il solido profilo creditizio e l'attenzione all'export del Gruppo Vitrolife.
Vitrolife (OTC:VTRLY) ha asegurado con éxito un acuerdo de préstamo por 300 millones de euros que comprende un préstamo a plazo y una línea de crédito revolvente. La financiación, respaldada por bancos nórdicos líderes como Nordea, SEB y el nuevo prestamista AB Svensk Exportkredit, tiene un plazo de tres años con dos opciones de extensión de un año cada una.
El préstamo a plazo se utilizará para refinanciar la deuda existente, mientras que la línea de crédito revolvente estará disponible para fines corporativos generales. La incorporación de AB Svensk Exportkredit como nuevo prestamista resalta el sólido perfil crediticio y el enfoque en exportaciones del Grupo Vitrolife.
Vitrolife (OTC:VTRLY)� 3� 유로 규모� 대� 계약� 성공적으� 체결했습니다. � 계약은 만기 대출과 회전 신용 한도� 구성되어 있으�, Nordea, SEB � 신규 대출기관� AB Svensk Exportkredit � 주요 북유� 은행들� 지원합니다. 대� 기간은 3년이�, 1년씩 � 차례 연장 옵션� 포함되어 있습니다.
만기 대출은 기존 부채를 재융자하� � 사용되며, 회전 신용 한도� 일반 기업 목적� 활용� 예정입니�. AB Svensk Exportkredit� 신규 대출기관 합류� Vitrolife 그룹� 강력� 신용 프로필과 수출 중심 전략� 강조합니�.
Vitrolife (OTC:VTRLY) a conclu avec succès un accord de prêt de 300 millions d'euros comprenant un prêt à terme et une facilité de crédit renouvelable. Ce financement, soutenu par des banques nordiques majeures telles que Nordea, SEB, ainsi que le nouvel prêteur AB Svensk Exportkredit, présente une durée de trois ans avec deux options de prolongation d'un an chacune.
Le prêt à terme sera utilisé pour refinancer la dette existante, tandis que la facilité de crédit renouvelable sera disponible pour des besoins généraux de l'entreprise. L'ajout d'AB Svensk Exportkredit en tant que nouveau prêteur souligne le solide profil de crédit et l'orientation export du groupe Vitrolife.
Vitrolife (OTC:VTRLY) hat erfolgreich eine Darlehensvereinbarung über 300 Millionen Euro abgeschlossen, die ein Termindarlehen und eine revolvierende Kreditfazilität umfasst. Die Finanzierung, unterstützt von führenden nordischen Banken wie Nordea, SEB und dem neuen Kreditgeber AB Svensk Exportkredit, hat eine Laufzeit von drei Jahren mit zwei Verlängerungsoptionen von jeweils einem Jahr.
Das Termindarlehen wird zur Refinanzierung bestehender Schulden verwendet, während die revolvierende Kreditfazilität für allgemeine Unternehmenszwecke zur Verfügung steht. Die Aufnahme von AB Svensk Exportkredit als neuen Kreditgeber unterstreicht das starke Kreditprofil und den Exportfokus der Vitrolife-Gruppe.
- Secured substantial EUR 300 million financing facility
- Added new lender AB Svensk Exportkredit while maintaining existing banking relationships
- Obtained flexible terms with 3-year tenor and two one-year extension options
- Demonstrated strong credit profile through successful refinancing
- None.
The loan agreement is backed by leading Nordic banks, with Nordea and SEB renewing their commitments and AB Svensk Exportkredit joining as a new lender, underscoring the Vitrolife Group's strong credit profile and focus on export. The loan agreement has a tenor of three-years and includes two one-year extension options.
"We appreciate the support from our existing and new banking partners in connection with this refinancing. This successful transaction underlines the confidence in the Vitrolife Group," says Bronwyn Brophy O'Connor, CEO of the Vitrolife Group.
VITROLIFE AB (publ)
Bronwyn Brophy O'Connor, CEO
Contact:
Amelie Wilson, Investor relations, external corporate communications and executive support,[email protected]
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision
The following files are available for download:
| Vitrolife Group completes refinancing facility backed by leading Nordic Banks |
View original content:
SOURCE Vitrolife AB (publ)